Search
Search Results
##search.searchResults.foundPlural##
-
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1549PDF: 720HTML: 223 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1675PDF: 544HTML: 258 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2736PDF: 899HTML: 7299 -
Osteolytic bone lesions – A rare presentation of AML M6.
1925PDF: 1051HTML: 7899Untitled: 183 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1502PDF: 853HTML: 964figures: 150table 1: 162table2: 160table3: 161 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2016PDF: 962HTML: 4050Cover Letter: 205Figure 1: 202Figure 2: 211Table 1: 187 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
1954PDF: 611HTML: 242 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
2713PDF: 932HTML: 3100flowcytometric result of peripheral blood sample: 156 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
736PDF: 466HTML: 92 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1930PDF: 733HTML: 3099 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3035PDF: 856HTML: 1523Fig.1 CHL-R paper: 189Fig 2 CHL-R paper: 219 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
389PDF: 200HTML: 70 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277536PDF: 1749HTML: 3836 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1687PDF: 956HTML: 1768Tables: 162 -
The diagnostic pitfalls of mucormycosis
825PDF: 687HTML: 229 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2365PDF: 1249HTML: 1716CoverLetter: 158 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1012PDF: 1000HTML: 420 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1773PDF: 878HTML: 930Referring article: 715 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4190PDF: 1333HTML: 2023 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1346PDF: 693Suppl. Files: 294Html: 120 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1678PDF: 1041HTML: 226 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1617PDF: 1055HTML: 10688Untitled: 162







